Dr. Drucker received his M.D. from the University of Toronto in 1980, and is currently Professor of Medicine at the University of Toronto. He holds a Canada Research Chair in Regulatory Peptides and the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology. His laboratory is based in the Lunenfeld Tanenbaum Research Institute at Mt. Sinai Hospital and studies the molecular biology and physiology of the glucagon-like peptides. Dr. Drucker’s scientific studies identified multiple novel mechanisms of gut hormone action, resulting in 33 issued US patents, and enabling development of new drug classes for diabetes, obesity and intestinal failure. His discoveries have been recognized by numerous learned societies including the Banting Award from the ADA, the Claude Bernard Award from the EASD, the Manpei Suzuki International Prize for Diabetes Research, the Rolf Luft Award from the Karolinska Institute, the Harrington-ASCI Prize for Innovation in Medicine, and election to Fellowship, the Royal Society, London.
Daniel J. Drucker
Senior Scientist, Lunenfeld Tanenbaum Research Institute Mt. Sinai Hospital
600 University Avenue TCP5-1004 Mailbox 39 Toronto Ontario M5G 1X5
Canada V 416-361-2661 F 416-361-2669 email@example.com